Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis

NCT05715320 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

160

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis

Interventions

BIOLOGICAL: CM310

Sponsor

Keymed Biosciences Co.Ltd